# SRTAW (Strata Critical Medical, Inc.) - SEC EDGAR Financial Statements

> Strata Critical Medical, Inc. reported $280.8M in revenue and a net loss of $24.81M for the trailing twelve months ended September 30, 2026 (up 50.3% year over year), with a 21.6% gross margin and a -6.6% operating margin.

- Canonical: https://convexityos.com/fundamentals/SRTAW
- Markdown: https://convexityos.com/fundamentals/SRTAW.md
- SEC CIK: 0001779128
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:35 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001779128&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $280.8M | +50.3% YoY |
| Operating Income | TTM | -$18.62M | -6.6% margin |
| Net Income | TTM | -$24.81M | -8.8% net margin |
| Diluted EPS | TTM | -$0.28 | Split-adjusted |
| Free Cash Flow | TTM | $806K | 0.3% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $41.64M | Total debt: $3.62M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $197.1M | $146.8M | $225.2M | $146.1M | $50.53M | -- | $23.43M | $31.20M |
| Cost of Revenue | $156.0M | $117.2M | $183.1M | $123.8M | $40.01M | -- | $21.11M | $26.50M |
| **Gross Profit** | $41.13M | $29.59M | $42.12M | $22.27M | $10.52M | -- | $2.33M | $4.70M |
| Selling, General & Admin | $60.88M | $50.86M | $105.6M | $70.26M | $32.93M | -- | $11.82M | $15.49M |
| Total Operating Expenses | $63.48M | $52.11M | -$33.23M | -$36.57M | -$24.94M | $678K | -- | -- |
| **Operating Income** | -$22.35M | -$22.52M | -$68.12M | -$53.53M | -$24.09M | -$678K | -$10.36M | -$11.54M |
| **EBITDA** | -$14.17M | -$16.56M | -$61.01M | -$47.80M | -$23.50M | -- | -$9.83M | -$11.07M |
| Income Before Tax | -$20.07M | -$16.16M | -$57.54M | -$28.03M | -$43.70M | $338K | -$10.16M | -$10.84M |
| Income Tax Expense | $0 | $0 | -$1.47M | -$772K | -$3.64M | $210K | $0 | $0 |
| **Net Income** | $41.35M | -$27.31M | -$56.08M | -$27.26M | -$40.05M | $128K | -$10.16M | -$10.84M |
| Basic EPS | $0.50 | -$0.35 | -$0.76 | -$0.38 | -$0.93 | -$0.05 | -$0.40 | -$0.43 |
| **Diluted EPS** | $0.50 | -$0.35 | -$0.76 | -$0.38 | -$0.93 | -$0.05 | -$0.40 | -$0.43 |
| Basic Shares Outstanding | 82.1M | 77.5M | 73.5M | 71.2M | 42.9M | 8.2M | 25.2M | 25.1M |
| Diluted Shares Outstanding | 82.1M | 77.5M | 73.5M | 71.2M | 42.9M | 8.2M | 25.2M | 25.1M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $74.08M | $72.51M | $67.38M | $66.79M | $49.30M | $45.11M | $35.95M | $36.39M |
| Cost of Revenue | $57.26M | $57.29M | $53.27M | $52.38M | $38.64M | $36.10M | $28.89M | $31.37M |
| **Gross Profit** | $16.82M | $15.21M | $14.12M | $14.41M | $10.65M | $9.01M | $7.05M | $5.01M |
| Selling, General & Admin | $15.14M | $14.00M | $15.61M | $19.34M | $15.91M | $13.29M | $12.33M | $49.50M |
| Total Operating Expenses | $20.65M | $20.62M | $17.09M | $20.82M | $16.28M | $13.65M | $12.74M | -- |
| **Operating Income** | -$3.83M | -$5.41M | -$2.97M | -$6.41M | -$5.62M | -$4.64M | -$5.68M | -$5.90M |
| **EBITDA** | $3.48M | $3.11M | $86K | -$3.40M | -$3.92M | -$2.87M | -$3.99M | -$4.37M |
| Income Before Tax | -$7.62M | -$10.52M | $2.40M | -$5.39M | -$9.66M | -$3.41M | -$1.61M | -$7.43M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$7.62M | -$10.52M | $2.15M | -$8.83M | $57.42M | -$3.74M | -$3.49M | -$9.79M |
| Basic EPS | -$0.09 | -$0.12 | $0.03 | -- | $0.70 | -$0.05 | -$0.04 | -- |
| **Diluted EPS** | -$0.09 | -$0.12 | $0.03 | -- | $0.70 | -$0.05 | -$0.04 | -- |
| Basic Shares Outstanding | 88.3M | 86.2M | 85.3M | -- | 82.5M | 81.3M | 79.9M | -- |
| Diluted Shares Outstanding | 88.3M | 86.2M | 90.2M | -- | 82.5M | 81.3M | 79.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 | FY 2020 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $30.97M | $18.38M | $27.87M | $41.34M | $2.60M | $6.95M | $846K | $12.16M | $1.31M |
| Short-Term Investments | $30.26M | $108.8M | $138.3M | $150.7M | $279.4M | $297.2M | -- | $0 | -- |
| **Cash & Short-Term Investments** | $61.23M | $127.1M | $166.1M | $192.1M | $282.0M | $304.1M | $846K | $12.16M | $1.31M |
| Accounts Receivable, Net | $39.96M | $19.82M | $21.00M | $10.88M | $5.55M | $3.77M | -- | $1.09M | -- |
| Other Current Assets | $5.01M | $509K | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $126.2M | $160.7M | $206.3M | $218.1M | $294.9M | $314.4M | $896K | $14.38M | $1.43M |
| Property, Plant & Equipment, Net | $36.44M | $28.46M | $2.90M | $2.04M | $2.04M | $1.96M | -- | $1.76M | -- |
| Goodwill | $88.21M | $15.54M | $13.33M | $39.45M | $13.33M | $13.27M | -- | $0 | -- |
| Intangible Assets | $47.50M | $7.96M | $20.52M | $46.37M | $24.42M | $12.64M | -- | $533K | -- |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | $276.9M | $277.3M | $276.3M |
| Other Non-Current Assets | $24.02M | $118K | $1.40M | $1.36M | $232K | $220K | -- | $107K | -- |
| **Total Non-Current Assets** | $199.3M | $95.93M | $88.68M | $106.9M | $40.94M | $28.95M | $276.9M | $3.34M | $276.3M |
| **Total Assets** | $325.5M | $256.7M | $294.9M | $325.0M | $335.9M | $343.4M | $277.8M | $17.71M | $277.7M |
| Deferred Revenue (Current) | -- | $6.66M | $6.84M | $6.71M | $5.98M | $4.65M | -- | $3.97M | -- |
| Other Current Liabilities | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $19.79M | $22.73M | $35.49M | $26.61M | $12.78M | $9.53M | $391K | $6.34M | $371K |
| Long-Term Debt | -- | -- | -- | $0 | -- | -- | -- | -- | -- |
| Other Non-Current Liabilities | $22.07M | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $26.61M | $12.01M | $25.15M | $23.93M | $31.73M | $42.63M | $46.39M | $291K | $9.62M |
| **Total Liabilities** | $46.40M | $34.74M | $60.64M | $50.54M | $44.51M | $52.16M | $46.78M | $6.63M | $10.00M |
| **Total Debt (incl. Leases)** | $3.31M | $9.32M | $24.52M | $18.33M | $716K | $653K | -- | $721K | -- |
| Common Stock | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | -- | $3.0K | -- |
| Retained Earnings | -$145.6M | -$186.9M | -$159.8M | -$103.7M | -$76.42M | -$77.19M | -$18.19M | -$37.14M | $785K |
| Accumulated Other Comp. Income | $0 | $1.75M | $3.96M | $2.29M | -$898K | -$297K | -- | $0 | -- |
| **Total Stockholders' Equity** | $279.1M | $221.9M | $234.3M | $274.5M | $291.4M | $291.2M | $10.00M | $11.08M | $5.00M |
| Total Equity | $279.1M | $221.9M | $234.3M | $274.5M | $291.4M | $291.2M | $10.00M | $11.08M | $5.00M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $35.14M | $16.32M | $58.72M | $30.97M | $22.75M | $58.75M | $34.83M | $18.38M |
| Short-Term Investments | $6.50M | $6.44M | $66K | $30.26M | $53.16M | $54.67M | $85.18M | $108.8M |
| **Cash & Short-Term Investments** | $41.64M | $22.75M | $58.79M | $61.23M | $75.92M | $113.4M | $120.0M | $127.1M |
| Accounts Receivable, Net | $42.77M | $43.41M | $39.60M | $39.96M | $37.54M | $28.17M | $22.13M | $19.82M |
| Other Current Assets | $6.91M | $6.34M | $6.17M | $5.01M | -- | -- | -- | $509K |
| **Total Current Assets** | $125.1M | $121.0M | $124.1M | $126.2M | $122.5M | $156.5M | $152.3M | $160.7M |
| Property, Plant & Equipment, Net | $39.62M | $40.70M | $40.09M | $36.44M | $38.56M | $33.70M | $32.57M | $28.46M |
| Goodwill | $101.9M | $106.9M | $88.59M | $88.21M | $84.61M | $44.25M | $42.04M | $15.54M |
| Intangible Assets | $58.83M | $60.01M | $46.31M | $47.50M | $49.75M | $13.58M | $13.53M | $7.96M |
| Other Non-Current Assets | $88K | $90K | $24.29M | $24.02M | $8.57M | $1.46M | $1.45M | $118K |
| **Total Non-Current Assets** | $203.7M | $211.7M | $203.5M | $199.3M | $212.6M | $101.4M | $98.24M | $95.93M |
| **Total Assets** | $328.9M | $332.7M | $327.6M | $325.5M | $335.1M | $257.9M | $250.6M | $256.7M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | $9.11M | $8.01M | $6.66M |
| Other Current Liabilities | $29.90M | $26.34M | -- | $0 | -- | -- | -- | -- |
| **Total Current Liabilities** | $45.12M | $45.78M | $20.94M | $19.79M | $27.87M | $26.31M | $21.88M | $22.73M |
| Other Non-Current Liabilities | $4.36M | $4.13M | $17.12M | $22.07M | $18.26M | -- | -- | $0 |
| **Total Non-Current Liabilities** | $7.39M | $7.60M | $20.95M | $26.61M | $24.20M | $8.51M | $8.94M | $12.01M |
| **Total Liabilities** | $52.51M | $53.38M | $41.89M | $46.40M | $52.08M | $34.82M | $30.82M | $34.74M |
| **Total Debt (incl. Leases)** | $3.62M | $4.25M | $4.47M | $3.31M | $3.47M | $8.84M | $9.07M | $9.32M |
| Common Stock | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K |
| Retained Earnings | -$161.5M | -$153.9M | -$143.4M | -$145.6M | -$136.7M | -$194.1M | -$190.4M | -$186.9M |
| Accumulated Other Comp. Income | $0 | $0 | $0 | $0 | $0 | $5.97M | $3.07M | $1.75M |
| **Total Stockholders' Equity** | $276.4M | $279.3M | $285.7M | $279.1M | $283.0M | $223.1M | $219.7M | $221.9M |
| Total Equity | $276.4M | $279.3M | $285.7M | $279.1M | $283.0M | $223.1M | $219.7M | $221.9M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $41.35M | -$27.31M | -$56.08M | -$27.26M | -$40.05M | $128K | -$10.16M | -$10.84M |
| Depreciation & Amortization | $8.19M | $5.96M | $7.11M | $5.72M | $596K | -- | $526K | $472K |
| Stock-Based Compensation | $17.83M | $19.89M | $12.50M | $8.28M | $9.62M | -- | $490K | $317K |
| Change in Receivables | -$12.03M | -$998K | -$10.25M | -$5.35M | -$414K | -- | -$591K | -$165K |
| **Operating Cash Flow** | -$48.91M | -$2.52M | -$32.35M | -$37.13M | -$15.62M | -$794K | -$10.82M | -$10.30M |
| Capital Expenditure | -$9.60M | -$30.86M | -$2.11M | -$730K | -$297K | -- | -$377K | -$604K |
| **Free Cash Flow** | -$58.51M | -$33.38M | -$34.46M | -$37.86M | -$15.91M | -- | -$11.20M | -$10.91M |
| Acquisitions, Net | -$66.53M | -$2.23M | $0 | -$48.10M | -$23.07M | -- | $0 | $0 |
| **Investing Cash Flow** | $69.75M | -$1.02M | $17.09M | $79.34M | -$321.3M | $335K | -$377K | -$1.05M |
| Share Repurchases | $0 | -$244K | $0 | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | -$8.91M | -$5.76M | -$76K | -$1.08M | $332.3M | -- | $1.18M | $116K |
| **Net Change in Cash** | $11.59M | -$9.37M | -$15.40M | $41.20M | -$4.69M | -$460K | -$10.02M | -$11.24M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$7.62M | -$10.52M | $2.15M | -$8.83M | $57.42M | -$3.74M | -$3.49M | -$9.79M |
| Depreciation & Amortization | $7.31M | $8.52M | $3.06M | $3.01M | $1.70M | $1.78M | $1.70M | $1.53M |
| Stock-Based Compensation | $5.05M | $3.71M | $5.04M | $6.59M | $1.68M | $5.35M | $4.22M | $4.53M |
| Change in Receivables | $1.36M | -$666K | $149K | -$3.48M | -$1.77M | -$6.26M | -$520K | $2.61M |
| **Operating Cash Flow** | $9.46M | $5.69M | $3.88M | -$8.31M | -$37.30M | -$3.06M | -$246K | -$1.75M |
| Capital Expenditure | -$400K | -$2.49M | -$5.18M | -$1.85M | -$2.90M | -$2.23M | -$2.61M | -$4.58M |
| **Free Cash Flow** | $9.06M | $3.20M | -$1.29M | -$10.15M | -$40.20M | -$5.30M | -$2.86M | -$6.33M |
| **Investing Cash Flow** | $13.46M | -$43.88M | $24.73M | $18.27M | $2.40M | $28.68M | $20.41M | $3.98M |
| **Financing Cash Flow** | -$4.10M | -$4.21M | -$859K | -$1.74M | -$1.79M | -$1.14M | -$4.25M | -$3.87M |
| **Net Change in Cash** | $18.82M | -$42.41M | $27.75M | $8.22M | -$37.30M | $24.63M | $16.04M | -$1.76M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 20.9% | 20.2% | 18.7% | 15.2% | 20.8% | -- | 9.9% | 15.1% |
| **Operating Margin** | -11.3% | -15.3% | -30.3% | -36.6% | -47.7% | -- | -44.2% | -37.0% |
| **Net Profit Margin** | 21.0% | -18.6% | -24.9% | -18.7% | -79.3% | -- | -43.4% | -34.7% |
| Return on Equity (ROE) | 14.8% | -12.3% | -23.9% | -9.9% | -13.8% | 1.3% | -91.7% | -- |
| Return on Assets (ROA) | 12.7% | -10.6% | -19.0% | -8.4% | -11.7% | 0.0% | -57.4% | -- |
| Current Ratio | 6.38x | 7.07x | 5.81x | 8.20x | 32.99x | 2.29x | 2.27x | -- |
| Quick Ratio | 5.11x | 6.47x | 5.27x | 7.63x | 32.30x | 2.17x | 2.09x | -- |
| Debt to Equity | 0.01x | 0.04x | 0.10x | 0.07x | 0.00x | -- | 0.07x | -- |
| **Revenue Growth (YoY)** | +34.3% | -34.8% | +54.1% | -- | +115.6% | -- | -24.9% | -- |
| Gross Profit Growth (YoY) | +39.0% | -29.8% | +89.1% | -- | +352.0% | -- | -50.5% | -- |
| 5Y Net Income / Share Growth | +3139.4% | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 21.6% | 21.3% | 21.1% | 20.9% | 19.0% | 18.6% | 20.4% | 20.3% |
| **Operating Margin** | -6.6% | -8.0% | -8.6% | -11.3% | -13.1% | -15.2% | -17.5% | -18.2% |
| **Net Profit Margin** | -8.8% | 15.7% | 20.6% | 21.0% | 24.2% | -12.4% | -15.1% | -14.2% |
| Return on Equity (ROE) | -9.0% | 14.4% | 16.4% | 14.8% | 14.3% | -8.5% | -12.1% | -12.3% |
| Return on Assets (ROA) | -7.5% | 12.1% | 14.3% | 12.7% | 12.1% | -7.4% | -10.6% | -10.6% |
| Current Ratio | 2.77x | 2.64x | 5.93x | 6.38x | 4.39x | 5.95x | 6.96x | 7.07x |
| Quick Ratio | 1.87x | 1.45x | 4.70x | 5.11x | 4.07x | 5.38x | 6.50x | 6.47x |
| Debt to Equity | 0.01x | 0.02x | 0.02x | 0.01x | 0.01x | 0.04x | 0.04x | 0.04x |
| **Revenue Growth (YoY)** | +50.3% | +60.7% | +87.4% | +83.5% | +36.7% | -33.6% | -30.2% | -23.4% |
| Gross Profit Growth (YoY) | +57.9% | +68.9% | +100.2% | +187.4% | +41.9% | -44.9% | -30.4% | -44.4% |
| **Net Income Growth (YoY)** | -113.3% | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -112.9% | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -686.9% | -136.4% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
